BioSpace News Archive

Wouldn’t it be great if a protein could help you lose weight? (And wouldn’t it even be better if it tasted great on pizza?)

VTU Technology GmbH announced today the change of its company name to VALIDOGEN GmbH following a reorganization of VTU Holding GmbH.

Anatara Lifesciences to announce the formation of its Product Development Advisory Board.

D3A will support important research projects with potential to create meaningful new medicines for dementia

Shares of Ann Arbor, Mich.-based Esperion Therapeutics are up more than 7 percent in premarket trading after the company announced on Sunday that planned to seek regulatory approval for its cholesterol-lowering therapy that hit the mark in a Phase III trial.

There are many reasons employees elect to remain at a given job: good salary and benefits, a strong sense of mission or duty, convenience, and so on. There are also many reasons that employees decide to leave a job – and one very common reason is management.

Genetic testing has become an important medical standard for families with known histories of hereditary disease. Individuals who choose to go through the mental and emotional process of taking a genetic test and absorbing the potentially life-changing conclusions may be disturbed to find out that results of such tests are not always consistent.

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announces that data from a phase I study assessing the safety and tolerability of its lead drug candidate SNF472 in haemodialysis patients has been published in the British Journal of Clinical Pharmacology.

Large Study Demonstrates that Expanded Carrier Screening Informs

Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options